Immix Biopharma (IMMX) Gains from Investment Securities (2020 - 2026)
Quarterly results put Gains from Investment Securities at -$34153.0 for Q1 2026, down 100.83% from a year ago — trailing twelve months through Mar 2026 was -$18522.0 (down 100.45% YoY), and the annual figure for FY2025 was $5.3 million, up 234.83%.
Immix Biopharma has reported Gains from Investment Securities over the past 7 years, most recently at -$34153.0 for Q1 2026.
- Gains from Investment Securities reached -$34153.0 in Q1 2026 per IMMX's latest filing, down from $5.3 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $5.3 million in Q4 2025 and bottomed at -$34153.0 in Q1 2026.
- Median Gains from Investment Securities over the past 5 years was $1.2 million (2022), compared with a mean of $1.5 million.
- The largest annual shift saw Gains from Investment Securities skyrocketed 46183.38% in 2025 before it tumbled 100.83% in 2026.
- Over 5 years, Gains from Investment Securities stood at $1.8 million in 2022, then soared by 41.85% to $2.5 million in 2023, then tumbled by 37.43% to $1.6 million in 2024, then skyrocketed by 234.83% to $5.3 million in 2025, then crashed by 100.65% to -$34153.0 in 2026.
- Business Quant data shows Gains from Investment Securities for IMMX at -$34153.0 in Q1 2026, $5.3 million in Q4 2025, and $21760.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34,153.00 |
| Mar 31, 2026 | -34,153.00 |
| Dec 31, 2025 | 5.26 Mn |
| Dec 31, 2025 | 5.26 Mn |
| Sep 30, 2025 | 21,760.00 |
| Sep 30, 2025 | 21,760.00 |
| Jun 30, 2025 | 19,989.00 |
| Jun 30, 2025 | 19,989.00 |
| Mar 31, 2025 | 4.09 Mn |
| Mar 31, 2025 | 4.09 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | 17,915.00 |
| Sep 30, 2024 | 17,915.00 |
| Jun 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 8,839.00 |
| Mar 31, 2024 | 8,839.00 |
| Dec 31, 2023 | 2.51 Mn |
| Dec 31, 2023 | 2.51 Mn |
| Sep 30, 2023 | 742,670.00 |
| Sep 30, 2023 | 742,670.00 |
| Jun 30, 2023 | 1.77 Mn |
| Jun 30, 2023 | 1.77 Mn |
| Mar 31, 2023 | 5,170.00 |
| Mar 31, 2023 | 5,170.00 |
| Dec 31, 2022 | 1.77 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 1.77 Mn |
| Sep 30, 2022 | 1.77 Mn |
| Jun 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 1.19 Mn |
| Mar 31, 2022 | 1,622.00 |
| Mar 31, 2022 | 1,622.00 |
| Dec 31, 2021 | 1.76 Mn |
| Dec 31, 2021 | 1.76 Mn |
| Dec 31, 2020 | 291,984.00 |
| Dec 31, 2020 | 291,984.00 |